Orally active insulin mimics: where do we stand now?

被引：0
作者：
M. Balasubramanyam
V. Mohan
机构：
[1] Madras Diabetes Research Foundation (MDRF),
来源：
Journal of Biosciences | 2001年 / 26卷
关键词：
Insulin mimetic; insulin receptor tyrosine kinase; PI 3-kinase; vanadium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The war against diabetes through the development of new drugs is an ongoing continuous process to counter the alarming global increase in the prevalence of diabetes and its complications, particularly in developing countries like India. Unfortunately, the speed with which our knowledge of diabetes and its effects is expanding is not matched by the availability of new drugs. Following the identification of the insulin receptor (IR), its intrinsic kinase activity and molecular cloning, many studies have looked at IR as an ideal drug target. This review summarizes in brief the latest advancements in this field with particular reference to the current situation in respect of the development of orally active insulin mimetics in the treatment of type 2 diabetes.
引用
收藏
页码：383 / 390
页数：7
相关论文
共 377 条
  • [1] Accili D(2001)Early neonatal death in mice homozygous for a null allele of the insulin receptor gene Nat. Genet. 12 106-109
  • [2] Drago J(1998)Mechanism of activation and function of protein kinase B Curr. Opin. Genet. Dev. 8 55-62
  • [3] Lee E J(2000)2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases J. Biol. Chem. 275 7101-7108
  • [4] Johnson M D(1989)Traditional plant medicines as treatments for diabetes Diabetes Care 12 553-564
  • [5] Cool M H(1997)Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen) Mol. Endocrinol. 11 1899-1910
  • [6] Salvatore P(1995)Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis Mol. Cell. Biochem. 153 49-58
  • [7] Asico L D(1999)Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats Int. J. Pharm. 183 117-123
  • [8] Jose P A(1992)Oral vanadate decreases muscle insulin resistance in obese fa/fa rats Diabetologia 35 522-527
  • [9] Taylor S I(1990)Insulin-sensitive tyrosine kinase: relationship with Am. J. Physiol. 258 E964-974
  • [10] Westphal H(2000) insulin action in humans Can. J. Physiol. Pharmacol. 78 829-847
12345678910